Alumna Working on Anti-Cancer Therapies

PI_Tolani_Vivi-Cell-Culture-560x420

Lung cancer is the deadliest form of the disease, claiming approximately 158,000 American lives and accounting for around 27 percent of all cancer deaths. One Hood College alumna is researching drug therapies to fight it.

Bhairavi (Vivi) Tolani is working with a three-person group studying anti-cancer targeted therapies for lung cancer. They are trying to find ways to shut down the rapid growth of the cancerous cells through a variety of drug combinations.

Keep reading.